- Home
- ALLO vs MERC Comparison
ALLO vs MERC Comparison
Compare ALLO & MERC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALLO | MERC |
|---|---|---|
| Founded | 2017 | 1968 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 597.7M | 25.9M |
| IPO Year | 2018 | 2005 |
Fundamental Metrics
Financial Performance| Metric | ALLO | MERC |
|---|---|---|
| Price | $1.70 | $0.38 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 3 |
| Target Price | ★ $8.35 | $2.25 |
| AVG Volume (30 Days) | ★ 4.8M | 3.4M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 7.01% |
| EPS Growth | ★ 34.09 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,169,145,000.00 |
| Revenue This Year | N/A | $13.75 |
| Revenue Next Year | $142,416.42 | $10.12 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 25.50 |
| 52 Week Low | $1.04 | $0.35 |
| 52 Week High | $4.46 | $2.96 |
Technical Indicators
Market Signals| Indicator | ALLO | MERC |
|---|---|---|
| Relative Strength Index (RSI) | 35.42 | 43.38 |
| Support Level | $1.59 | $0.35 |
| Resistance Level | $1.92 | $0.65 |
| Average True Range (ATR) | 0.08 | 0.03 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 6.58 | 73.59 |
Price Performance
Historical ComparisonAbout ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
About MERC Mercer International Inc.
Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the maximum of revenue is generated from the China. The majority of the revenue is generated from the Pulp segment.